The global Intragastric Gas Balloon and Liquid Balloon market size is predicted to grow from US$ 134 million in 2025 to US$ 224 million in 2031; it is expected to grow at a CAGR of 8.9% from 2025 to 2031.

An intragastric balloon is a non-surgical weight-loss medical device used to treat obesity. It is inserted into the stomach using an endoscopic procedure and then inflated with saline or gas to occupy part of the stomach's volume. This helps reduce food intake, increase satiety, and assist patients in managing their weight.

The global market for intragastric balloons is growing, driven by rising obesity rates and increasing demand for non-surgical weight-loss solutions.

Key Features:

• Minimally invasive and reversible.
• Shorter recovery times compared to surgical methods.
• Typically removed after 6 to 12 months.

Segmentation by Type:

• Gas Balloon
• Liquid Balloon

Segmentation by Application:

• Male
• Female

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company Coverage:

• Boston Scientific (Apollo Endosurgery）
• ReShape Lifesciences
• Allurion
• Helioscopie
• Endalis
• MEDSIL
• Spatz Medical
• Lexel
• Districlass Medical
• Silimed
• Changzhou Panda Medical

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Intragastric Gas Balloon and Liquid Balloon market?
• What factors are driving Intragastric Gas Balloon and Liquid Balloon market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Intragastric Gas Balloon and Liquid Balloon market opportunities vary by end market size?
• How does Intragastric Gas Balloon and Liquid Balloon break out by Type, by Application?